OutSee

OutSee is a developer of an artificial intelligence engine for predictive genomics. The AI engine predicts disease and phenotype directly from a single genome, uncovering biological mechanisms that drive and modulate disease rather than matching known genetic associations. The technology can find additional results after other methods have been fully exploited, predicting complex genetics including multi-variant effects and mechanistically cooperative interactions. This allows grouping patients in ways that improve therapeutic targeting and diagnostic accuracy. Founded and headquartered in the United Kingdom, OutSee has raised approximately 5.8 million at the Seed stage with investors including Ahren, Kadmos Capital, Empirical Ventures, and Panacea Venture.